Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FACILITATE-HF
NCT07397650Phase 4Recruiting
- Sponsor
- Juntendo University
- Start
- May 2026
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Acute Heart Failure (AHF) comparing Finerenone with Placebo (2 arms). Primary endpoint: Hierarchical composite endpoint of death and worsening heart failure at 12 weeks. Started May 2026; status: recruiting.
02
Drugs
finerenone
03
Conditions
Acute Heart Failure (AHF)
Beyond the preview
Go deeper on NCT07397650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07397650.